Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about AbbVie Inc

Recent news which mentions AbbVie Inc

< Previous 1 2 Next >
Jim Cramer suggests why it's hard to own traditional 'safety' stocks here
Tags Business General Mills Inc stocks
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Novo Nordisk A/S Abbvie Inc Biotech and Pharmaceuticals
From CNBC.com News
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
Tags Politics Health & Science Breaking News: Politics
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Novo Nordisk A/S Abbvie Inc Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags Biotech and Pharmaceuticals Abbvie Inc Abbott Laboratories
From CNBC.com News
Cramer's week ahead: Earnings from Tesla, Alphabet, Capital One and Boeing
Tags Business News Lockheed Martin Corp Kimberly/Clark Corp
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags Breaking News: Politics Health & Science Business
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Bristol/Myers Squibb Co Breaking News: Markets Health care industry
From CNBC.com News
Ad spending on women's sports more than doubled last year
Tags AT&T Inc Marketing and advertising Business
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Salesforce Inc AstraZeneca PLC Alphabet Inc
From CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
Tags Mad Money MongoDB Inc Tempus AI Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags GSK plc AstraZeneca PLC Health & Science
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Stock markets Investing KB Home
From CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
Tags Market Outlook Business News Sweetgreen Inc
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Eli Lilly and Co Arthur J/ Gallagher & Co/ stocks
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Health & Science Social issues Eli Lilly and Co
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Healthy Returns Biotech and Pharmaceuticals Abbvie Inc
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags Healthy Returns Teva Pharmaceutical Industries Ltd Biotech and Pharmaceuticals
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Tags Biotechnology Business News Abbvie Inc
From CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
Tags Breaking News: Business US: News Space industry
From CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
Tags Stock markets Markets U/S/ Markets
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Health & Science Business Abbvie Inc
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
Tags Health & Science Business Breaking news
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags Investment strategy Abbvie Inc ImmunoGen Inc
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
Tags Health & Science Business Moderna Inc
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Investment strategy 5 Things to Know Citigroup Inc
From CNBC.com News
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Tags Health care industry Pharmaceuticals Cerevel Therapeutics Holdings Inc
From CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Tags Business News Biotechnology ADC Therapeutics SA
From CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
Tags Chevron Corp CNBC Investing Club Western Digital Corp
From CNBC.com News
Cramer's Lightning Round: Energy Transfer is a buy
Tags Markets U/S/ Markets S&P 500
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.